Reminder, Interim Analysis of P2b RESTORE-CLI Webcast, Aastrom Biosciences (ASTM)
ASTM will present data from an interim analysis of its Phase 2b RESTORE-CLI clinical trial at a VEITHsymposium™ non-CME satellite session.
This event will include a webcast presentation by Dr. Richard Powell, RESTORE-CLI principal investigator and a Q&A session with Dr. Powell, co-principal investigator, Dr. William Marston, CEO Tim Mayleben and Dr. Sharon Watling, vice president of clinical and regulatory at ASTM.
- When: Thursday, 11/18/10 @ 1:00 pm (ET)
- Where: http://www.aastrom.com/investor.cfm
- How: The conference call will be available live in the Investors section of Aastrom’s website at http://www.aastrom.com/investor.cfm;
- Please access the site at least 15 minutes prior to the scheduled start time in order to download the required audio software if necessary (RealPlayer or Windows Media Player).
- A podcast will also be available after the live event at http://www.aastrom.com/events.cfm.
If you are unable to participate during the live call, the webcast will be available for replay at http://www.aastrom.com/events.cfm for up to 90 days. A replay of the call will also be available until 12:00 am (ET) on Thursday, 11/25/10 by calling (800) 642-1687, or from outside the U.S. at (706) 645-9291.
- The pass code for the replay is 24654952.
